James E. Crowe, Jr.
41Patents
8h-index
45Co-inventors
75Inventor score
Filing activity: Apr 24, 1990 → May 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5762905A | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 55 | Expired |
| US5922326A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 55 | Expired |
| US6685942B1 | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Emerging Cross-Sectional Technologies | 45 | Expired |
| US7488477B2 | Neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 23 | Expired |
| US8221759B2 | Neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 15 | Active |
| US7867497B2 | Monoclonal antibodies to respiratory syncytial virus and uses therefor | Chemistry; Metallurgy | 15 | Active |
| US7364737B2 | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5092777A | Alphabet teaching and learning game and method thereof | Physics | 12 | Expired |
| US5882651A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 8 | Expired |
| US5161976A | Alphabet teaching and learning game and method thereof | Physics | 7 | Expired |
| US11345741B2 | Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Physics | 3 | Active |
| US8969622B2 | Dendritic molecular intracellular transporters and methods of making and using same | Emerging Cross-Sectional Technologies | 3 | Active |
| US10479825B2 | Antibody-mediated neutralization of Marburg virus | Chemistry; Metallurgy | 2 | Active |
| US11021533B2 | Human Zika virus antibodies and methods of use therefor | Emerging Cross-Sectional Technologies | 2 | Active |
| US10117924B2 | Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions | Emerging Cross-Sectional Technologies | 1 | Active |
| US6284254A | Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants | Chemistry; Metallurgy | 1 | Expired |
| US11524994B2 | Antibodies to human respiratory syncytial virus protein F pre-fusion conformation and methods of use therefor | Physics | 0 | Active |
| US10787503B2 | Antibody-mediated neutralization of Chikungunya virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US11939370B2 | Pan-ebola virus neutralizing human antibodies and methods of use therefor | Physics | 0 | Active |
| US12410241B2 | Human monoclonal antibodies to enterovirus D68 | Emerging Cross-Sectional Technologies | 0 | Active |
| US12037384B2 | Human monoclonal antibodies against yellow fever virus and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US10981979B2 | Human monoclonal antibodies to Staphylococcus aureus lukab toxin | Physics | 0 | Active |
| US12226471B2 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US11084869B2 | Antibody-mediated neutralization of Marburg virus | Chemistry; Metallurgy | 0 | Active |
| US12233127B2 | Human monoclonal antibodies to a new universal influenza A hemagglutinin head domain epitope | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.